Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Daniel Addison"'
Autor:
Harjit Singh, Michael T. Lu, James Uldeson, Travis R. Hallett, Harold Litt, Udo Hoffmann, Anna Chang, Fabian Bamberg, Sumbal A Janjua, Judd E. Hollander, Chadwick D. Miller, Daniel O. Bittner, Pamela K. Woodard, Thomas Mayrhofer, Daniel Addison, Christopher L. Schlett, Quynh A. Truong, John T. Nagurney, Maros Ferencik
Publikováno v:
Circulation. 142
Introduction: A disparity in health outcomes between black and white patients with coronary artery disease (CAD) has also been reported with pathophysiological differences in CAD and racial disparities in providing health care as potential explanatio
Autor:
Adam C. Calaway, Lee Ponsky, Avirup Guha, Nihar R. Desai, Courtney M. Campbell, Michael G. Fradley, Daniel J. Lenihan, Daniel Addison, Kathleen W. Zhang, Arjun K Ghosh, Neal L. Weintraub, Jorge A. Garcia
Publikováno v:
Circulation. 142
Introduction: Hormone therapy has been associated with adverse cardiovascular events including arterial vascular events in men with prostate cancer. It is unclear if the risk of arterial vascular events varies by type of hormone therapy used. Methods
Autor:
Emefah Loccoh, Ajay Vallakati, Patrick Ruz, Daniel Addison, Jeremy Slivnick, Lisa Kim, Terence M. Williams, Ahmet S. Ayan, Reynaldo Sanchez, Ragavendra R. Baliga, Eric D. Miller, Uzoma Anaba
Publikováno v:
Current cardiology reports. 22(11)
Radiation-induced cardiovascular disease, including coronary artery disease, is a well-known sequela of radiation therapy and represents a significant source of morbidity and mortality for cancer survivors. This review examines current literature and
Autor:
Pedro V. Staziaki, Michael T. Lu, James L. Januzzi, Sandeep Hedgire, Brian B. Ghoshhajra, John T. Nagurney, Daniel O. Bittner, Daniel Addison, Sumbal Janjua, Udo Hoffmann, Jan-Erik Scholtz, Borek Foldyna, Tomas G. Neilan, N. Meyersohn
Publikováno v:
JACC: Cardiovascular Imaging. 11:1369-1371
Coronary computed tomography angiography (CTA) is an excellent tool for ruling out coronary artery disease (CAD) in low-risk patients [(1)][1]. High-sensitivity troponin assays have proven safety and efficacy in ruling out large numbers of patients w
Autor:
Jan-Erik, Scholtz, Daniel, Addison, Daniel O, Bittner, Sumbal, Janjua, Borek, Foldyna, Sandeep, Hedgire, Pedro V, Staziaki, James L, Januzzi, John T, Nagurney, Nina, Meyersohn, Michael T, Lu, Tomas G, Neilan, Udo, Hoffmann, Brian B, Ghoshhajra
Publikováno v:
JACC. Cardiovascular imaging. 11(9)
Autor:
Jane E. Freedman, James G. Terry, Venkatesh L. Murthy, Daniel Addison, Aferdita Spahillari, Robert J. Mentz, Ravi V. Shah, J. Jeffrey Carr, Jared P. Reis, Joao A.C. Lima, Adolfo Correa, Udo Hoffmann, Stanford Mwasongwe
Publikováno v:
JAMA cardiology. 2(6)
Modern prevention guidelines substantially increase the number of individuals who are eligible for treatment with statins. Efforts to refine statin eligibility via coronary calcification have been studied in white populations but not, to our knowledg
Autor:
Daniel Addison, Mahboob Alam, Vu Hoang, Francisco Y. Macedo, Salim S. Virani, Yochai Birnbaum
Publikováno v:
Cardiovascular drugs and therapy. 30(2)
Current practice guidelines support the use of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin-receptor blockers (ARBs) in patients with coronary artery disease (CAD) without heart failure (HF). However, a number of cited trials were
Publikováno v:
Circulation. 130
Background: Data from randomized-controlled trials regarding the efficacy of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARBs) in patients with coronary artery disease (CAD) but no evidence of heart failure are
Autor:
Salim S. Virani, Vu Hoang, Francisco Y. Macedo, Daniel Addison, Mahboob Alam, Yochai Birnbaum
Publikováno v:
Cardiovascular Drugs and Therapy. 30:199-199
Publikováno v:
Journal of the American College of Cardiology. (12):A1428
Data from randomized-controlled trials of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) in patients with coronary artery disease (CAD) but no clinical evidence of heart failure are inconclusive. This study wa